Flinn
Enables MedTech companies to automate quality & regulatory processes to launch and operate products 10x more efficient.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €10.0m | Early VC | |
| Total Funding | 000k | ||
| USD | 2023 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Flinn.ai is a cutting-edge startup focused on revolutionizing the way medical device manufacturers manage their compliance processes. The company operates in the MedTech (medical technology) sector, providing innovative solutions to streamline Post Market Surveillance (PMS) activities. PMS involves monitoring the safety and performance of medical devices after they have been released to the market, which is crucial for ensuring ongoing compliance with regulatory standards.
Flinn.ai's primary product is an AI-assisted platform that automates the collection, evaluation, and documentation of PMS data. This platform integrates seamlessly with other Quality Management (QM) and Regulatory Affairs (RA) processes, making it a comprehensive tool for MedTech companies. By leveraging artificial intelligence, Flinn.ai's solution can efficiently gather data from multiple sources, filter out irrelevant information, and provide fast, accurate evaluations. This not only increases productivity but also ensures that all documentation is compliant with Medical Device Regulation (MDR) standards.
The company's business model is likely subscription-based, offering its platform as a Software-as-a-Service (SaaS). This model allows clients to pay a recurring fee for access to the software, ensuring a steady revenue stream for Flinn.ai. The primary clients are medical device manufacturers who need to maintain high standards of compliance and efficiency in their operations. By automating labor-intensive tasks, Flinn.ai helps these companies reduce costs, minimize risks, and accelerate the time-to-market for their products.
In summary, Flinn.ai empowers medical device manufacturers to automate and optimize their compliance processes, significantly enhancing efficiency and ensuring regulatory adherence. The company's innovative AI-driven platform is a game-changer in the MedTech industry, offering a robust solution for PMS activities.
Keywords: AI, MedTech, compliance, PMS, automation, efficiency, MDR, SaaS, data evaluation, regulatory.